Pharmaceuticals

Ursodeoxycholic Acid Market 2026 growing toward $1.6 billion by 2030

March 25, 2026March 25, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Ursodeoxycholic Acid Market In 2026 And What Value Is Projected For 2030?

The ursodeoxycholic acid market has witnessed rapid expansion in recent years. Its valuation is expected to climb from $0.96 billion in 2025 to $1.06 billion in 2026, representing a compound annual growth rate (CAGR) of 11.0%. The historical growth of this market can be attributed to several factors, including restricted production methods for ursodeoxycholic acid, a reliance on extraction from animal sources, increasing public awareness of liver disease management, a rise in treatments provided by hospitals and specialty clinics, and limited research into non-alcoholic fatty liver disease.

The ursodeoxycholic acid market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $1.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This growth during the forecast timeframe is attributable to advancements in chemical and enzymatic synthesis, an increasing incidence of liver and biliary diseases, the proliferation of specialty clinics and research institutions, a rise in regulatory approvals for synthetic UDCA, and the creation of novel administration formulations. Key trends for the projection period encompass a growing occurrence of gallstones and cholestatic liver disorders, broader adoption of synthetic and biosynthetic UDCA, the broadening of oral and intravenous administration routes, expanding application in research and clinical trials for liver diseases, and an emphasis on personalized treatment and dosage optimization.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24734&type=smp

What Key Drivers Are Influencing The Growth Of The Ursodeoxycholic Acid Market?

The growing occurrence of liver diseases is anticipated to boost the ursodeoxycholic acid market. Liver diseases encompass various ailments that impede the liver’s proper functioning, such as infections, inflammation, fatty liver, cirrhosis, and liver cancer. This increase in liver disease prevalence stems from higher alcohol intake, which can cause liver damage over time. Ursodeoxycholic acid aids in treating liver conditions by enhancing bile flow and diminishing harmful bile acids, proving beneficial for issues like primary biliary cholangitis. It also improves patient results by decelerating liver damage and assisting in the dissolution of cholesterol gallstones, thereby boosting treatment effectiveness. For example, data from April 2024, provided by the Office for Health Improvement and Disparities, a UK-based government department, indicated 6,664 premature deaths from liver disease among males and 3,929 among females. This represented a 22.8% rise for males and a 33.1% rise for females compared to 2023. Consequently, the rising prevalence of liver diseases is a significant factor propelling the ursodeoxycholic acid market.

What Are The Key Segments Of The Ursodeoxycholic Acid Market?

The ursodeoxycholic acid market covered in this report is segmented –

1) By Type: Synthetic Ursodeoxycholic Acid, Extraction Ursodeoxycholic Acid

2) By Route Of Administration: Oral, Intravenous, Subcutaneous

3) By Application: Gallstones, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Non-Alcoholic Fatty Liver Disease, Other Liver And Biliary Diseases

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

5) By End User: Hospitals, Specialty Clinics, Research Institutions, Other End Users

Subsegments:

1) By Synthetic Ursodeoxycholic Acid: Chemically Synthesized Ursodeoxycholic Acid, Biosynthetic Ursodeoxycholic Acid, Enzymatically Synthesized Ursodeoxycholic Acid

2) By Extraction Ursodeoxycholic Acid: Animal-Derived Ursodeoxycholic Acid, Bile Extracted Ursodeoxycholic Acid, Natural Source Extracted Ursodeoxycholic Acid

What Key Trends Are Influencing The Development Of The Ursodeoxycholic Acid Market?

Leading companies operating within the ursodeoxycholic acid (UDCA) market are focusing on creating innovative treatments, such as bile acid derivatives, to enhance the management of liver diseases, particularly cholestatic liver disorders. Bile acid derivatives refer to altered forms of bile acids utilized in medical therapies to improve liver function and address liver conditions. For instance, in November 2024, Nora Pharma Inc., a Canada-based pharmaceutical company, launched a generic version of Ursodiol (ursodeoxycholic acid) for the treatment of cholestatic liver diseases, including primary biliary cholangitis (PBC). This medication is primarily employed to boost liver functionality and slow the advancement of liver damage, especially when therapy commences early in the disease. It also assists in dissolving and preventing cholesterol gallstones by modifying bile composition and reducing toxic bile acids.

Who Are The Leading Companies Operating In The Ursodeoxycholic Acid Market?

Major companies operating in the ursodeoxycholic acid market are Mankind Pharma Pvt. Ltd, Abbott Healthcare Pvt. Ltd., Shandong Octagon Chemicals Limited, J.S.C. Grindeks, Arch Pharmalabs, Ind Swift Laboratories Ltd., Symbiotec Pharmalab, Suzhou Tianlu Bio-pharmaceutical Co. Ltd, Zeal MediPharma, Prodotti Chimici e Alimentari S.P.A., Mitsubishi Tanabe Pharma Corporation, ICE Pharma Inc, Xi’an Tian Guangyuan Biotech Co. Ltd, Aamorb Pharmaceuticals Inc., Axplora Inc, Octavius Pharma Pvt. Ltd, Sichuan Elixir Pharmaceutical Co. Ltd, Signova Pharma Pvt. Ltd., Sinoway Industrial Co. Ltd, Valence Labs Pvt. Ltd.

Read the full ursodeoxycholic acid market report here:

https://www.thebusinessresearchcompany.com/report/ursodeoxycholic-acid-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Ursodeoxycholic Acid Market?

North America was the largest region in the ursodeoxycholic acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ursodeoxycholic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Ursodeoxycholic Acid Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24734&type=smp

Browse Through More Reports Similar to the Global Ursodeoxycholic Acid Market 2026, By The Business Research Company

Glutamic Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/glutamic-acid-global-market-report

Hyaluronic Acid Based Dermal Fillers Market Report 2026

https://www.thebusinessresearchcompany.com/report/hyaluronic-acid-based-dermal-fillers-global-market-report

Citric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/citric-acid-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795